# OnCo record inbrx-106 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/inbrx-106/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "inbrx-106" ;
  schema:name "INBRX-106"@en ;
  schema:alternateName "Hexavalent OX40 agonist antibody"@en ;
  schema:description "INBRX-106 is an experimental monoclonal antibody from Inhibrx Biosciences in phase 3 trials for head and neck squamous cell carcinoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/inbrx-106/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=INBRX-106>, <https://inhibrx.com/pipeline/> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:companies <https://onco.cc/companies/inhibrx/> ;
  onco:trials <https://onco.cc/trials/nct06295731/> .